Humalog and Moviprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate). Common drug interactions include chronic kidney disease among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Moviprep. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

On Aug, 02, 2026

14 people who take Humalog and Moviprep together, and have interactions are studied.

What are the common drug interactions of Humalog and Moviprep, by gender? *:

female:

Chronic kidney disease
Activities of daily living impaired
Blood glucose increased
Drug abuse
Dysgeusia (disorder of the sense of taste)
Ear infection
Eye infection
Fluid retention (an abnormal accumulation of fluid in the blood)
Glycosylated haemoglobin increased
Infection

male:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Dyspnoea (difficult or laboured respiration)
Failure to thrive (inadequate weight gain and physical growth in children)
Femur fracture
Fluid overload (too much fluid in the blood)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Lung neoplasm (tumour of lung)

What are the common drug interactions of Humalog and Moviprep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)

50-59:

Blood glucose fluctuation
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dizziness postural
Failure to thrive (inadequate weight gain and physical growth in children)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Peripheral swelling
Pleural effusion (water on the lungs)
Pneumonia

60+:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Weight decreased
Glycosylated haemoglobin increased
Infection
Loss of consciousness
Mass
Memory impairment
Pneumonia
Stress
Sudden death

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 35.71%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 35.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 28.57%
Nausea (feeling of having an urge to vomit): 4 people, 28.57%
Depression: 4 people, 28.57%
Constipation: 4 people, 28.57%
High Blood Pressure: 4 people, 28.57%
Muscle Spasms (muscle contraction): 3 people, 21.43%
Pain: 3 people, 21.43%
Infection: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Moviprep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously